Stacy Cline Amin spoke to Bloomberg Law about the Biden administration's decision to activate FDA [U.S. Food and Drug Administration] emergency powers for monkeypox, which could quintuple the U.S. vaccine supply, though the latest action doesn't use that authority to boost treatment options.
"I was surprised to see that it just covers vaccines," Stacy said. "I'm glad to see the declaration for vaccines. But there's an urgent need for more accessible therapeutics," Stacy said.
She added that she expects to see an emergency use authorization determination for diagnostics and therapeutics to follow shortly after the one for vaccines.
"I under I understand that measures have been taken to ease access to therapeutic products, but really, I think emergency use authorization should be considered as well because it could potentially, significantly reduce the bureaucracy involved in patients getting access to therapeutics that are desperately needed," Stacy said.
Read the full article (subscription required).
Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Morrison & Foerster LLP. All rights reserved
